Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruilian Xie

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Artificial Cells, Nanomedicine, and Biotechnology|June 18, 2016
Integrated bioinformatics analysis of miRNA expression in osteosarcomaMaoyuan Wang, Ruilian Xie, Haibo Si, et al.
Molecular Medicine Reports|July 25, 2012
p16 promoter hypermethylation is associated with increased breast cancer riskLi Wang, Lin Tang, Ruilian Xie, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 8, 2026
Comparing tumor burden-based classification with traditional methods for knowledge-based VMAT planning in multiple brain metastasesZhenzhen Lai, Houjin Zhang, Ruilian Xie, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 3, 2014
Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinomaRuilian Xie, Yanru Wang, Weiwei Nie, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 24, 2019
Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast CancerRuilian Xie, Maoyuan Wang, Wenting Zhou, et al.
Annals of Translational Medicine|August 5, 2021
Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature reviewLongqiu Wu, Wenjuan Zhong, An Li, et al.
Journal of Cellular and Molecular Medicine|March 21, 2009
p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysisXiaoxiang Guan, Yucai Wang, Ruilian Xie, et al.
Radiation Oncology (London, England)|January 20, 2025
Sequential or simultaneous-integrated boost in early-stage breast cancer patients: trade-offs between skin toxicity and risk of compromised coverageChangyou Zhong, Minfeng Huang, Haidong Yu, et al.
Arthritis Research & Therapy|December 4, 2025
Maternal-fetal outcomes and therapeutic strategies in pregnancies complicated by Takayasu arteritis: a comprehensive analysisWangjin Chen, Ruilian Xie, Yushuang Xiao, et al.
Physics in Medicine and Biology|April 26, 2024
Dosimetric evaluation of different planning strategies for hypofractionated whole-breast irradiation techniqueChunbo Tang, Biaoshui Liu, Jun Yuan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Artificial Cells, Nanomedicine, and Biotechnology|June 18, 2016
Integrated bioinformatics analysis of miRNA expression in osteosarcomaMaoyuan Wang, Ruilian Xie, Haibo Si, et al.
Molecular Medicine Reports|July 25, 2012
p16 promoter hypermethylation is associated with increased breast cancer riskLi Wang, Lin Tang, Ruilian Xie, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 8, 2026
Comparing tumor burden-based classification with traditional methods for knowledge-based VMAT planning in multiple brain metastasesZhenzhen Lai, Houjin Zhang, Ruilian Xie, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 3, 2014
Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinomaRuilian Xie, Yanru Wang, Weiwei Nie, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 24, 2019
Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast CancerRuilian Xie, Maoyuan Wang, Wenting Zhou, et al.
Annals of Translational Medicine|August 5, 2021
Successful treatment of EGFR T790M-mutant non-small cell lung cancer with almonertinib after osimertinib-induced interstitial lung disease: a case report and literature reviewLongqiu Wu, Wenjuan Zhong, An Li, et al.
Journal of Cellular and Molecular Medicine|March 21, 2009
p27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysisXiaoxiang Guan, Yucai Wang, Ruilian Xie, et al.
Radiation Oncology (London, England)|January 20, 2025
Sequential or simultaneous-integrated boost in early-stage breast cancer patients: trade-offs between skin toxicity and risk of compromised coverageChangyou Zhong, Minfeng Huang, Haidong Yu, et al.
Arthritis Research & Therapy|December 4, 2025
Maternal-fetal outcomes and therapeutic strategies in pregnancies complicated by Takayasu arteritis: a comprehensive analysisWangjin Chen, Ruilian Xie, Yushuang Xiao, et al.
Physics in Medicine and Biology|April 26, 2024
Dosimetric evaluation of different planning strategies for hypofractionated whole-breast irradiation techniqueChunbo Tang, Biaoshui Liu, Jun Yuan, et al.
Pageof 2